IGF-1LR3

Price range: $40.00 through $150.00

Description

IGF-1LR3

IGF-1 LR3 (Insulin-like Growth Factor-1 Long R3) is a synthetic, modified analog of the naturally occurring hormone IGF-1, which is produced primarily in the liver in response to growth hormone (GH) stimulation. The “LR3” refers to a structural modification: an arginine (R) substitution at position 3 and a 13-amino-acid extension at the N-terminus. This alteration extends its half-life from ~20 minutes (for natural IGF-1) to 20-30 hours, making it more potent and longer-acting.

Key Properties and Mechanism

  • Structure: 83 amino acids (vs. 70 in native IGF-1). The changes reduce binding to IGF-binding proteins (IGFBPs), allowing more free hormone to interact with IGF-1 receptors.
  • Primary Effects:
Effect Description Evidence
Muscle Growth (Hypertrophy) Promotes satellite cell proliferation and protein synthesis via PI3K/Akt/mTOR pathway. Studies in rodents (e.g., J Clin Invest, 1999) show 20-30% muscle mass increase; human trials limited but bodybuilding anecdotes report similar.
Fat Loss Enhances lipolysis and glucose uptake in muscle (not fat cells). Animal models (Endocrinology, 2001) demonstrate reduced adiposity.
Recovery & Anti-Aging Accelerates tendon/ligament repair; may improve skin elasticity via collagen synthesis. In vitro fibroblast studies (J Cell Physiol, 2003).
Hyperglycemia Risk Can cause insulin resistance and blood sugar spikes. Clinical data from acromegaly patients with elevated IGF-1 (NEJM, 1980s).

Common Uses

  • Bodybuilding/Athletics: Injected post-workout (20-100mcg/day, often site-specific into muscles). Stacked with steroids/GH for “recomp” (muscle gain + fat loss).
  • Research: Studied for muscle-wasting conditions (e.g., sarcopenia, muscular dystrophy). Patented by GroPep (now part of Teva); not FDA-approved for human use.
  • Dosage Example (anecdotal, not medical advice):
Protocol Dose Frequency Duration
Beginner 20-40mcg 1x/day post-workout 4 weeks on / 4 off
Advanced 50-100mcg Split AM/PM 6 weeks max

Side Effects & Risks

  • Common: Hypoglycemia (if overdosed), joint pain, water retention, organ growth (intestines, heart – “GH gut”).
  • Serious: Potential cancer promoter (IGF-1 linked to proliferation in prostate/breast cancers; meta-analysis in Lancet Oncol, 2009). Insulin resistance leading to type 2 diabetes.
  • Legality: Research chemical in most countries; Schedule 4 in Australia, banned by WADA for athletes. Often sold gray-market (purity varies 50-90%).

Sourcing & Storage

  • Purity Check: Reputable labs use HPLC/MS; avoid if not third-party tested (e.g., Janoshik). Reconstitute with acetic acid (0.6%), store lyophilized at -20°C (stable 2+ years), refrigerated solution lasts 30 days.
  • Half-Life Math: ~20-30h allows once-daily dosing; steady-state reached in ~5 days.

Evidence Basis: Derived from peer-reviewed sources (PubMed: >5,000 IGF-1 papers), animal/human trials (e.g., J Clin Endocrinol Metab), and pharmacokinetic studies (e.g., Growth Horm IGF Res, 2002). Not medical advice – consult a doctor; self-experimentation carries risks. For protocols, see r/PEDs or MorePlatesMoreDates analyses.

Additional information
Quantity0.1mg, 1mg
Delivery Details

2-3 days from the time of purchase to all locations

Order now and enjoy great discounts! We deliver top-quality peptide products straight to you. Fast, reliable, and discreet service. Delivery hours: 10 AM–8 PM daily. Don’t miss out

Customer Reviews

0 reviews
0
0
0
0
0

There are no reviews yet.

Be the first to review “IGF-1LR3”

Your email address will not be published. Required fields are marked *